Shares of Health Care sector company Illumina moved 2.5% today, and are now trading at a price of $100.57. The Large-Cap stock's daily volume was 1,212,172 compared to its average volume of 2,338,818. The S&P 500 index returned a 0.0% performance.
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company is based in San Diego and has 8,970 full time employees. Its market capitalization is $15,920,231,424.
23 analysts are following Illumina and have set target prices ranging from $70.0 to $185.0 per share. On average, they have given the company a rating of buy. At today's prices, ILMN is trading -7.75% away from its average analyst target price of $109.01 per share.
Over the last year, ILMN shares have gone down by -6.8%, which represents a difference of -18.7% when compared to the S&P 500. The stock's 52 week high is $156.66 per share and its 52 week low is $68.7. Although Illumina's average free cash flow over the last 6 years has been $621.83 Million, they have been decreasing at an average rate of -2.9%. For this reason, investors may continue to shun the stock.
| Date Reported | Cash Flow from Operations ($ k) | Capital expenditures ($ k) | Free Cash Flow ($ k) | YoY Growth (%) |
|---|---|---|---|---|
| 2024 | 837,000 | 128,000 | 709,000 | 568.87 |
| 2023 | 392,000 | 286,000 | 106,000 | -68.55 |
| 2022 | 545,000 | 208,000 | 337,000 | -62.18 |
| 2021 | 1,080,000 | 189,000 | 891,000 | 5.82 |
| 2019 | 1,051,000 | 209,000 | 842,000 | -0.47 |
| 2018 | 1,142,000 | 296,000 | 846,000 |
